Literature DB >> 21569834

A cembranoid protects acute hippocampal slices against paraoxon neurotoxicity.

Vesna A Eterović1, Dinely Pérez, Antonio H Martins, Brenda L Cuadrado, Marimée Carrasco, P A Ferchmin.   

Abstract

Many neurotoxic organophosphates (OPs) inhibit acetylcholinesterase (AChE) and as a result can cause a life threatening cholinergic crisis. Current medical countermeasures, which typically include atropine and oximes target the cholinergic crisis and are effective in decreasing mortality but do not sufficiently protect against delayed neurological deficits. There is, therefore, a need to develop neuroprotective drugs to prevent long-term neurological deficits. We used acute hippocampal slices to test the hypothesis that 4R,6R-cembratrienediol (4R) protects against functional damage caused by the OP paraoxon (POX). To assess hippocampal function, we measured synaptically evoked population spikes (PSs). Application of 4R reversed POX inhibition of PSs and the EC(50) of this effect was 0.8 μM. Atropine alone did not protect against POX neurotoxicity, but it did enhance protection by 4R. Pralidoxime partially regenerated AChE activity and protected against POX inhibition of PSs. 4R did not regenerate AChE suggesting that under our experimental conditions, the deleterious effect of POX on hippocampal function is not directly related to AChE inhibition. In conclusion, 4R is a promising neuroprotective compound against OP neurotoxins.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21569834      PMCID: PMC3162106          DOI: 10.1016/j.tiv.2011.04.021

Source DB:  PubMed          Journal:  Toxicol In Vitro        ISSN: 0887-2333            Impact factor:   3.500


  26 in total

Review 1.  Therapy for nerve agent poisoning.

Authors:  Jonathan Newmark
Journal:  Arch Neurol       Date:  2004-05

2.  Inhibition with spontaneous reactivation of carboxyl esterases by organophosphorus compounds: paraoxon as a model.

Authors:  Jorge Estévez; Adolfo García-Pérez; José Barril; Eugenio Vilanova
Journal:  Chem Res Toxicol       Date:  2010-12-14       Impact factor: 3.739

3.  PRiMA: the membrane anchor of acetylcholinesterase in the brain.

Authors:  Anselme L Perrier; Jean Massoulié; Eric Krejci
Journal:  Neuron       Date:  2002-01-17       Impact factor: 17.173

4.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

5.  Characterizing neurotoxicity using the in vitro hippocampal brain slice preparation: heavy metals.

Authors:  S B Fountain; T J Teyler
Journal:  Prog Clin Biol Res       Date:  1987

6.  Unit analysis of hippocampal polulation spikes.

Authors:  P Andersen; T V Bliss; K K Skrede
Journal:  Exp Brain Res       Date:  1971       Impact factor: 1.972

7.  Spermine is neuroprotective against anoxia and N-methyl-D-aspartate in hippocampal slices.

Authors:  P A Ferchmin; D Pérez; M Biello
Journal:  Brain Res       Date:  2000-03-24       Impact factor: 3.252

8.  Organophosphorus compound-induced apoptosis in SH-SY5Y human neuroblastoma cells.

Authors:  K Carlson; B S Jortner; M Ehrich
Journal:  Toxicol Appl Pharmacol       Date:  2000-10-15       Impact factor: 4.219

9.  On-line visualization of dendritic release of acetylcholinesterase from mammalian substantia nigra neurons.

Authors:  R R Llinás; S A Greenfield
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

10.  A guinea pig hippocampal slice model of organophosphate-induced seizure activity.

Authors:  Patrick K Harrison; Robert D Sheridan; A Chris Green; Iain R Scott; John E H Tattersall
Journal:  J Pharmacol Exp Ther       Date:  2004-03-18       Impact factor: 4.030

View more
  12 in total

1.  Neuroprotection Against Diisopropylfluorophosphate in Acute Hippocampal Slices.

Authors:  P A Ferchmin; Dinely Pérez; Brenda L Cuadrado; Marimée Carrasco; Antonio H Martins; Vesna A Eterović
Journal:  Neurochem Res       Date:  2015-10-05       Impact factor: 3.996

2.  4R-cembranoid protects against diisopropylfluorophosphate-mediated neurodegeneration.

Authors:  P A Ferchmin; Myrna Andino; Rebeca Reyes Salaman; Janaina Alves; Joyce Velez-Roman; Brenda Cuadrado; Marimeé Carrasco; Wilmarie Torres-Rivera; Annabell Segarra; Antonio Henrique Martins; Jae Eun Lee; Vesna A Eterovic
Journal:  Neurotoxicology       Date:  2014-06-10       Impact factor: 4.294

3.  Neuroprotective activity of (1S,2E,4R,6R,-7E,11E)-2,7,11-cembratriene-4,6-diol (4R) in vitro and in vivo in rodent models of brain ischemia.

Authors:  Antonio H Martins; Jing Hu; Zhenfeng Xu; Chaofeng Mu; Paloma Alvarez; Byron D Ford; Khalid El Sayed; Vesna A Eterovic; Pedro A Ferchmin; Jiukuan Hao
Journal:  Neuroscience       Date:  2015-02-10       Impact factor: 3.590

4.  In Vivo Evaluation of the Acute Systemic Toxicity of (1S,2E,4R,6R,7E,11E)-Cembratriene-4,6-diol (4R) in Sprague Dawley Rats.

Authors:  Nadezhda Sabeva; Oné R Pagán; Yancy Ferrer-Acosta; Vesna A Eterović; Peter A Ferchmin
Journal:  Nutraceuticals (Basel)       Date:  2022-04-09

Review 5.  Structural Modifications and Biological Activities of Natural α- and β-Cembrenediol: A Comprehensive Review.

Authors:  Kuo Xu; Xinying Du; Xia Ren; XiuXue Li; Hui Li; Xianjun Fu; Xiaoyi Wei
Journal:  Pharmaceuticals (Basel)       Date:  2022-05-13

6.  γ-Aminobutyric acid type A receptor inhibition triggers a nicotinic neuroprotective mechanism.

Authors:  P A Ferchmin; Dinely Pérez; William Castro Alvarez; Mario A Penzo; Héctor M Maldonado; Vesna A Eterovic
Journal:  J Neurosci Res       Date:  2012-12-26       Impact factor: 4.164

7.  Protective activity of (1S,2E,4R,6R,7E,11E)-2,7,11-cembratriene-4,6-diol analogues against diisopropylfluorophosphate neurotoxicity: preliminary structure-activity relationship and pharmacophore modeling.

Authors:  Vesna A Eterović; Angelie Del Valle-Rodriguez; Dinely Pérez; Marimée Carrasco; Mohammad A Khanfar; Khalid A El Sayed; Pedro A Ferchmin
Journal:  Bioorg Med Chem       Date:  2013-05-24       Impact factor: 3.641

8.  4R-cembranoid protects neuronal cells from oxygen-glucose deprivation by modulating microglial cell activation.

Authors:  Hefei Fu; Jiapeng Wang; Jie Wang; Langni Liu; Jianxiong Jiang; Jiukuan Hao
Journal:  Brain Res Bull       Date:  2021-12-20       Impact factor: 4.077

9.  Pharmacokinetics and Metabolism of 4R-Cembranoid.

Authors:  Wanda Vélez-Carrasco; Carol E Green; Paul Catz; Anna Furimsky; Kathleen O'Loughlin; Vesna A Eterović; P A Ferchmin
Journal:  PLoS One       Date:  2015-03-26       Impact factor: 3.240

10.  4R-Cembranoid Improves Outcomes after 6-Hydroxydopamine Challenge in Both In vitro and In vivo Models of Parkinson's Disease.

Authors:  Jing Hu; P A Ferchmin; Ann M Hemmerle; Kim B Seroogy; Vesna A Eterovic; Jiukuan Hao
Journal:  Front Neurosci       Date:  2017-05-29       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.